Cantor Fitzgerald Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Cantor Fitzgerald
Rating: 2.7
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Cantor Fitzgerald. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Cantor Fitzgerald.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
CSGS CSG Systems International	$53.34 +15.1%	2/8/2024	Reiterated by	Cantor Fitzgerald	Analyst B. Knoblauch	Overweight -> Overweight	$63.00	Low	View details for Cantor Fitzgerald rating of CSG Systems International (NASDAQ:CSGS) on 2/8/2024
CVS CVS Health	$75.09 -1.3%	2/8/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$87.00	Low	View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 2/8/2024
AGIO Agios Pharmaceuticals	$24.18 +2.1%	2/8/2024	Initiated by	Cantor Fitzgerald	-	Overweight		Low	View details for Cantor Fitzgerald rating of Agios Pharmaceuticals (NASDAQ:AGIO) on 2/8/2024
FTNT Fortinet	$67.85 -3.1%	2/7/2024	Reiterated by	Cantor Fitzgerald	Analyst J. Ruykhaver	Neutral	$50.00 -> $75.00	Low	View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 2/7/2024
KE Kimball Electronics	$20.75 +4.4%	2/7/2024	Target Lowered by	Cantor Fitzgerald	-	Overweight -> Overweight	$33.00 -> $28.00	Low	View details for Cantor Fitzgerald rating of Kimball Electronics (NASDAQ:KE) on 2/7/2024
GILD Gilead Sciences	$73.80 -0.8%	2/7/2024	Target Lowered by	Cantor Fitzgerald	-	Neutral -> Neutral	$80.00 -> $78.00	Low	View details for Cantor Fitzgerald rating of Gilead Sciences (NASDAQ:GILD) on 2/7/2024
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
FRSH Freshworks	$21.36 +1.0%	2/7/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$25.00	Low	View details for Cantor Fitzgerald rating of Freshworks (NASDAQ:FRSH) on 2/7/2024
BBAI BigBear.ai	$1.72 +3.6%	2/7/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$3.00	Low	View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 2/7/2024
ORGO Organogenesis	$3.62 +1.7%	2/7/2024	Initiated by	Cantor Fitzgerald	-	Overweight	$5.00	Low	View details for Cantor Fitzgerald rating of Organogenesis (NASDAQ:ORGO) on 2/7/2024
VRTX Vertex Pharmaceuticals	$423.06 +0.9%	2/6/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$440.00	Low	View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 2/6/2024
ZFOX ZeroFox	$1.10 -0.9%	2/6/2024	Downgraded by	Cantor Fitzgerald	Analyst J. Ruykhaver	Overweight -> Neutral		Low	View details for Cantor Fitzgerald rating of ZeroFox (NASDAQ:ZFOX) on 2/6/2024
REGN Regeneron Pharmaceuticals	$946.43 +0.8%	2/6/2024	Target Raised by	Cantor Fitzgerald	-	Neutral -> Neutral	$850.00 -> $925.00	Low	View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 2/6/2024
ASND Ascendis Pharma A/S	$139.25 0.0%	2/6/2024	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$152.00 -> $173.00	Low	View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 2/6/2024
SMTI Sanara MedTech	$40.20 +4.1%	2/6/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$49.00	Low	View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 2/6/2024
JNJ Johnson & Johnson	$156.43 -1.0%	2/6/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight -> Overweight	$215.00	Low	View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 2/6/2024
SYM Symbotic	$42.99 +9.4%	2/6/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$60.00	Low	View details for Cantor Fitzgerald rating of Symbotic (NASDAQ:SYM) on 2/6/2024
NXPI NXP Semiconductors	$227.83 +2.9%	2/6/2024	Reiterated by	Cantor Fitzgerald	Analyst C. Muse	Overweight -> Overweight	$260.00	Low	View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 2/6/2024
MRK Merck & Co., Inc.	$126.61 -0.7%	2/5/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight -> Overweight	$135.00	Low	View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 2/5/2024
LCTX Lineage Cell Therapeutics	$1.08 +2.9%	2/5/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$6.00	N/A	View details for Cantor Fitzgerald rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 2/5/2024
CI The Cigna Group	$332.29 +0.5%	2/5/2024	Upgraded by	Cantor Fitzgerald	Analyst S. James	Neutral -> Overweight	$334.00 -> $372.00	Low	View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 2/5/2024
CRWD CrowdStrike	$323.04 +1.7%	2/2/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$240.00	Low	View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 2/2/2024
CRNX Crinetics Pharmaceuticals	$38.46 +1.8%	2/2/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$50.00	Low	View details for Cantor Fitzgerald rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 2/2/2024
COUR Coursera	$17.62 +0.8%	2/2/2024	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$22.00 -> $26.00	Low	View details for Cantor Fitzgerald rating of Coursera (NYSE:COUR) on 2/2/2024
INTC Intel	$42.50 -0.7%	2/2/2024	Reiterated by	Cantor Fitzgerald	Analyst C. Muse	Neutral -> Neutral	$50.00	Low	View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 2/2/2024
ELV Elevance Health	$502.05 +0.9%	2/2/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$547.00	Low	View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 2/2/2024
ACAD ACADIA Pharmaceuticals	$25.68 +1.9%	2/2/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$42.00	Low	View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 2/2/2024
TXN Texas Instruments	$160.21 +0.9%	2/2/2024	Reiterated by	Cantor Fitzgerald	-	Neutral -> Neutral	$170.00	Low	View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 2/2/2024
RDW Redwire	$3.02 +2.0%	2/2/2024	Initiated by	Cantor Fitzgerald	Analyst A. Sheppard	Overweight	$5.00	Low	View details for Cantor Fitzgerald rating of Redwire (NYSE:RDW) on 2/2/2024
NXT Nextracker	$57.12 +3.1%	2/1/2024	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$52.00 -> $62.00	Low	View details for Cantor Fitzgerald rating of Nextracker (NASDAQ:NXT) on 2/1/2024
QCOM QUALCOMM	$148.18 +1.6%	2/1/2024	Reiterated by	Cantor Fitzgerald	Analyst C. Muse	Neutral -> Neutral	$150.00	Low	View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 2/1/2024
NVO Novo Nordisk A/S	$118.39 -0.2%	2/1/2024	Target Raised by	Cantor Fitzgerald	Analyst L. Chen	Overweight -> Overweight	$120.00 -> $140.00	Low	View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 2/1/2024
LLY Eli Lilly and Company	$735.56 +1.4%	2/1/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight -> Overweight	$630.00	Low	View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 2/1/2024
RCKT Rocket Pharmaceuticals	$29.26 +1.2%	1/31/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$65.00	Low	View details for Cantor Fitzgerald rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 1/31/2024
TER Teradyne	$98.47 +1.0%	1/31/2024	Reiterated by	Cantor Fitzgerald	Analyst C. Muse	Neutral -> Neutral	$110.00	Low	View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 1/31/2024
PFE Pfizer	$27.56	1/31/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight -> Overweight	$45.00	Low	View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 1/31/2024
CYBR CyberArk Software	$261.60 +7.6%	1/31/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$210.00	Low	View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 1/31/2024
ZS Zscaler	$249.41 +1.9%	1/31/2024	Reiterated by	Cantor Fitzgerald	-	Neutral -> Neutral	$185.00	Low	View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 1/31/2024
EVEX EVE	$6.40 +1.1%	1/30/2024	Reiterated by	Cantor Fitzgerald	-	Neutral -> Neutral	$7.00	Low	View details for Cantor Fitzgerald rating of EVE (NYSE:EVEX) on 1/30/2024
ADI Analog Devices	$194.06 +1.1%	1/29/2024	Reiterated by	Cantor Fitzgerald	Analyst C. Muse	Neutral -> Neutral	$205.00	Low	View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 1/29/2024
AMD Advanced Micro Devices	$169.35 -0.9%	1/29/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$190.00	Low	View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 1/29/2024

AVGO Broadcom	$1,274.76 +1.4%	1/29/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$1,300.00	Low	View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 1/29/2024
KLAC KLA	$618.49 +1.6%	1/29/2024	Reiterated by	Cantor Fitzgerald	Analyst C. Muse	Neutral -> Neutral	$625.00	Low	View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 1/29/2024
LRCX Lam Research	$864.36 +1.9%	1/29/2024	Reiterated by	Cantor Fitzgerald	Analyst C. Muse	Neutral -> Neutral	$900.00	Low	View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 1/29/2024
NVDA NVIDIA	$696.41 -0.7%	1/29/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$775.00	Low	View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 1/29/2024
ACHR Archer Aviation	$5.18 +5.5%	1/29/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$10.00	Low	View details for Cantor Fitzgerald rating of Archer Aviation (NYSE:ACHR) on 1/29/2024
PTCT PTC Therapeutics	$25.25 +0.0%	1/26/2024	Target Lowered by	Cantor Fitzgerald	-	Overweight -> Overweight	$51.00 -> $45.00	Low	View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 1/26/2024
HUM Humana	$367.65 -0.2%	1/26/2024	Downgraded by	Cantor Fitzgerald	-	Overweight -> Neutral	$597.00 -> $391.00	Low	View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 1/26/2024
ELV Elevance Health	$502.05 +0.9%	1/25/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$547.00	Low	View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 1/25/2024
BITF Bitfarms	$2.52 +10.5%	1/25/2024	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$2.00 -> $3.00	Low	View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 1/25/2024
CIFR Cipher Mining	$2.90 +15.5%	1/25/2024	Target Lowered by	Cantor Fitzgerald	-	Overweight -> Overweight	$6.00 -> $5.00	Low	View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 1/25/2024
VRTX Vertex Pharmaceuticals	$423.06 +0.9%	1/24/2024	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$415.00 -> $440.00	Low	View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/24/2024
JNJ Johnson & Johnson	$156.43 -1.0%	1/23/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight -> Overweight	$215.00	Low	View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 1/23/2024
LLY Eli Lilly and Company	$735.56 +1.4%	1/23/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight -> Overweight	$630.00	Low	View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 1/23/2024
WDC Western Digital	$57.12 -1.4%	1/23/2024	Initiated by	Cantor Fitzgerald	-	Overweight -> Overweight	$70.00	Low	View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 1/23/2024
INTC Intel	$42.50 -0.7%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Neutral	$50.00	Low	View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 1/23/2024
TXN Texas Instruments	$160.21 +0.9%	1/23/2024	Initiated by	Cantor Fitzgerald	-	Neutral -> Neutral	$180.00	Low	View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 1/23/2024
TER Teradyne	$98.47 +1.0%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Neutral	$110.00	Low	View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 1/23/2024
KLAC KLA	$618.49 +1.6%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Neutral -> Neutral	$625.00	Low	View details for Cantor Fitzgerald rating of KLA (NASDAQ:KLAC) on 1/23/2024
STX Seagate Technology	$87.68 +1.1%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Neutral	$90.00	Low	View details for Cantor Fitzgerald rating of Seagate Technology (NASDAQ:STX) on 1/23/2024
LRCX Lam Research	$864.36 +1.9%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Neutral	$830.00	Low	View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 1/23/2024
QCOM QUALCOMM	$148.18 +1.6%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Neutral	$150.00	Low	View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 1/23/2024
MRVL Marvell Technology	$71.02 +2.4%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Overweight	$80.00	Low	View details for Cantor Fitzgerald rating of Marvell Technology (NASDAQ:MRVL) on 1/23/2024
NXPI NXP Semiconductors	$227.83 +2.9%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Overweight	$260.00	Low	View details for Cantor Fitzgerald rating of NXP Semiconductors (NASDAQ:NXPI) on 1/23/2024
MU Micron Technology	$84.88 -0.3%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Overweight	$100.00	Low	View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 1/23/2024
GFS GLOBALFOUNDRIES	$54.78 +4.3%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Overweight	$70.00	Low	View details for Cantor Fitzgerald rating of GLOBALFOUNDRIES (NASDAQ:GFS) on 1/23/2024
NVDA NVIDIA	$696.41 -0.7%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Overweight	$775.00	Low	View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 1/23/2024
AVGO Broadcom	$1,274.76 +1.4%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Overweight	$1,300.00	Low	View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 1/23/2024
ASML ASML	$922.94 +0.1%	1/23/2024	Initiated by	Cantor Fitzgerald	-	Overweight		Low	View details for Cantor Fitzgerald rating of ASML (NASDAQ:ASML) on 1/23/2024
AMAT Applied Materials	$173.89 +1.7%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Neutral	$180.00	Low	View details for Cantor Fitzgerald rating of Applied Materials (NASDAQ:AMAT) on 1/23/2024
ADI Analog Devices	$194.06 +1.1%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Neutral	$205.00	Low	View details for Cantor Fitzgerald rating of Analog Devices (NASDAQ:ADI) on 1/23/2024
AMD Advanced Micro Devices	$169.35 -0.9%	1/23/2024	Initiated by	Cantor Fitzgerald	Analyst C. Muse	Overweight	$190.00	Low	View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 1/23/2024
BBIO BridgeBio Pharma	$32.96 -2.4%	1/22/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$50.00	Low	View details for Cantor Fitzgerald rating of BridgeBio Pharma (NASDAQ:BBIO) on 1/22/2024
AXSM Axsome Therapeutics	$95.68 +1.8%	1/22/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$108.00	Low	View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 1/22/2024
RIOT Riot Platforms	$13.05 +15.3%	1/22/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$19.00	N/A	View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 1/22/2024
CI The Cigna Group	$332.29 +0.5%	1/19/2024	Reiterated by	Cantor Fitzgerald	-	Neutral -> Neutral	$334.00	Low	View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 1/19/2024
ELV Elevance Health	$502.05 +0.9%	1/19/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$547.00	Low	View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 1/19/2024
HCA HCA Healthcare	$305.46 -0.6%	1/19/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$315.00	Low	View details for Cantor Fitzgerald rating of HCA Healthcare (NYSE:HCA) on 1/19/2024
HUM Humana	$367.65 -0.2%	1/19/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$597.00	Low	View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 1/19/2024
UNH UnitedHealth Group	$520.01 +0.1%	1/19/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$591.00	Low	View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 1/19/2024
NNOX Nano-X Imaging	$5.74 +1.6%	1/19/2024	Target Lowered by	Cantor Fitzgerald	-	Overweight -> Overweight	$24.00 -> $18.00	Low	View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 1/19/2024
RCEL AVITA Medical	$17.60 +3.3%	1/19/2024	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$20.00 -> $22.00	Low	View details for Cantor Fitzgerald rating of AVITA Medical (NASDAQ:RCEL) on 1/19/2024
AXGN AxoGen	$9.87 +1.9%	1/19/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$12.00	Low	View details for Cantor Fitzgerald rating of AxoGen (NASDAQ:AXGN) on 1/19/2024
RARE Ultragenyx Pharmaceutical	$45.45 +1.7%	1/19/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$114.00	Low	View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 1/19/2024
ENVX Enovix	$10.70 +10.1%	1/18/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$30.00	Low	View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 1/18/2024
ALNY Alnylam Pharmaceuticals	$169.50 +0.5%	1/18/2024	Reiterated by	Cantor Fitzgerald	-	Neutral -> Neutral	$165.00	Low	View details for Cantor Fitzgerald rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 1/18/2024
KRTX Karuna Therapeutics	$316.12 +0.7%	1/17/2024	Reiterated by	Cantor Fitzgerald	-	Neutral -> Neutral	$330.00	Low	View details for Cantor Fitzgerald rating of Karuna Therapeutics (NASDAQ:KRTX) on 1/17/2024
ZVRA Zevra Therapeutics	$5.95 +2.4%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 1/12/2024
ZLAB Zai Lab	$19.61 -0.3%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 1/12/2024
THTX Theratechnologies	$1.57 -4.8%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Theratechnologies (NASDAQ:THTX) on 1/12/2024
TH Theratechnologies	C$2.13 -4.5%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		N/A	View details for Cantor Fitzgerald rating of Theratechnologies (TSE:TH) on 1/12/2024

ONC Oncolytics Biotech	C$1.37 +13.2%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		N/A	View details for Cantor Fitzgerald rating of Oncolytics Biotech (TSE:ONC) on 1/12/2024
SMRT SmartRent	$3.02 +1.0%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst B. Knoblauch	Overweight		Low	View details for Cantor Fitzgerald rating of SmartRent (NYSE:SMRT) on 1/12/2024
SCYX SCYNEXIS	$1.92 -4.0%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of SCYNEXIS (NASDAQ:SCYX) on 1/12/2024
PRCH Porch Group	$2.40 +7.6%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst J. Siegler	Overweight		Low	View details for Cantor Fitzgerald rating of Porch Group (NASDAQ:PRCH) on 1/12/2024
PDSB PDS Biotechnology	$5.26 -0.6%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of PDS Biotechnology (NASDAQ:PDSB) on 1/12/2024
PCVX Vaxcyte	$74.14 +0.9%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Vaxcyte (NASDAQ:PCVX) on 1/12/2024
ONCY Oncolytics Biotech	$1.02 +14.6%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Oncolytics Biotech (NASDAQ:ONCY) on 1/12/2024
NVO Novo Nordisk A/S	$118.39 -0.2%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 1/12/2024
MESO Mesoblast	$1.82 +1.7%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Mesoblast (NASDAQ:MESO) on 1/12/2024
LYRA Lyra Therapeutics	$4.81 -1.8%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Lyra Therapeutics (NASDAQ:LYRA) on 1/12/2024
LLY Eli Lilly and Company	$735.56 +1.4%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 1/12/2024
IMAB I-Mab	$1.79 -10.5%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of I-Mab (NASDAQ:IMAB) on 1/12/2024
HCM HUTCHMED	$13.93 +1.7%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of HUTCHMED (NASDAQ:HCM) on 1/12/2024
ATOS Atossa Therapeutics	$0.94 -1.1%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Atossa Therapeutics (NASDAQ:ATOS) on 1/12/2024
ARDX Ardelyx	$9.27 +3.3%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Ardelyx (NASDAQ:ARDX) on 1/12/2024
ANL Adlai Nortye	$8.86 -0.4%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Adlai Nortye (NASDAQ:ANL) on 1/12/2024
AMRN Amarin	$1.23 +2.5%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Amarin (NASDAQ:AMRN) on 1/12/2024
AMAM Ambrx Biopharma	$27.79	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Ambrx Biopharma (NYSE:AMAM) on 1/12/2024
ACRS Aclaris Therapeutics	$1.18 +11.3%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Neutral		Low	View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 1/12/2024
ALLK Allakos	$1.27 +0.8%	1/16/2024	Downgraded by	Cantor Fitzgerald	Analyst J. Kim	Overweight -> Neutral		N/A	View details for Cantor Fitzgerald rating of Allakos (NASDAQ:ALLK) on 1/16/2024
LBPH Longboard Pharmaceuticals	$19.32 -6.1%	1/16/2024	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$55.00 -> $60.00	Low	View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 1/16/2024
UBSFY Ubisoft Entertainment	$4.60 +11.1%	1/16/2024	Initiated by	Cantor Fitzgerald	-	Neutral		Low	View details for Cantor Fitzgerald rating of Ubisoft Entertainment (OTCMKTS:UBSFY) on 1/16/2024
IMVT Immunovant	$35.27 +0.1%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Immunovant (NASDAQ:IMVT) on 1/12/2024
LCID Lucid Group	$3.51 +3.8%	1/12/2024	Reiterated by	Cantor Fitzgerald	Analyst A. Sheppard	Neutral -> Neutral	$6.00	Low	View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 1/12/2024
PSNY Polestar Automotive Holding UK	$1.72 -3.9%	1/12/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$5.00	Low	View details for Cantor Fitzgerald rating of Polestar Automotive Holding UK (NASDAQ:PSNY) on 1/12/2024
CRWD CrowdStrike	$323.04 +1.7%	1/12/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$240.00	Low	View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 1/12/2024
PANW Palo Alto Networks	$367.02 +0.7%	1/12/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$280.00	Low	View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 1/12/2024
VRTX Vertex Pharmaceuticals	$423.06 +0.9%	1/9/2024	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$415.00	Low	View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 1/9/2024
MRK Merck & Co., Inc.	$126.61 -0.7%	1/9/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight -> Overweight	$135.00	Low	View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 1/9/2024
PRTA Prothena	$27.43 +3.1%	1/9/2024	Target Lowered by	Cantor Fitzgerald	-	Overweight -> Overweight	$129.00 -> $87.00	Low	View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 1/9/2024
PFE Pfizer	$27.56	1/9/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight -> Overweight	$45.00	Low	View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 1/9/2024
REGN Regeneron Pharmaceuticals	$946.43 +0.8%	1/9/2024	Reiterated by	Cantor Fitzgerald	-	Neutral -> Neutral	$850.00	Low	View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 1/9/2024
JNJ Johnson & Johnson	$156.43 -1.0%	1/9/2024	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight -> Overweight	$215.00	Low	View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 1/9/2024
BBAI BigBear.ai	$1.72 +3.6%	1/9/2024	Initiated by	Cantor Fitzgerald	-	Overweight	$3.00	Low	View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 1/9/2024
VERA Vera Therapeutics	$37.56 +0.1%	1/8/2024	Initiated by	Cantor Fitzgerald	Analyst P. Stavropoulos	Overweight		Low	View details for Cantor Fitzgerald rating of Vera Therapeutics (NASDAQ:VERA) on 1/8/2024
CSLR Complete Solaria	$1.39 +0.7%	1/8/2024	Initiated by	Cantor Fitzgerald	Analyst D. Soderberg	Overweight	$6.00	Low	View details for Cantor Fitzgerald rating of Complete Solaria (NASDAQ:CSLR) on 1/8/2024
CAPR Capricor Therapeutics	$3.98 +1.8%	1/5/2024	Initiated by	Cantor Fitzgerald	-	Overweight	$8.00	Low	View details for Cantor Fitzgerald rating of Capricor Therapeutics (NASDAQ:CAPR) on 1/5/2024
LBPH Longboard Pharmaceuticals	$19.32 -6.1%	1/2/2024	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$35.00 -> $55.00	Low	View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 1/2/2024
SPT Sprout Social	$63.10 +3.9%	1/2/2024	Upgraded by	Cantor Fitzgerald	-	Neutral -> Overweight	$48.00 -> $74.00	Low	View details for Cantor Fitzgerald rating of Sprout Social (NASDAQ:SPT) on 1/2/2024
CSGS CSG Systems International	$53.34 +15.1%	12/22/2023	Reiterated by	Cantor Fitzgerald	Analyst B. Knoblauch	Overweight		Low	View details for Cantor Fitzgerald rating of CSG Systems International (NASDAQ:CSGS) on 12/22/2023
RKLB Rocket Lab USA	$4.30 +0.7%	12/22/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$6.00	Low	View details for Cantor Fitzgerald rating of Rocket Lab USA (NASDAQ:RKLB) on 12/22/2023
ZVRA Zevra Therapeutics	$5.95 +2.4%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 12/18/2023
ZLAB Zai Lab	$19.61 -0.3%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 12/18/2023
ONC Oncolytics Biotech	C$1.37 +13.2%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		N/A	View details for Cantor Fitzgerald rating of Oncolytics Biotech (TSE:ONC) on 12/18/2023
SPRO Spero Therapeutics	$1.35 -6.9%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Spero Therapeutics (NASDAQ:SPRO) on 12/18/2023
SCYX SCYNEXIS	$1.92 -4.0%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of SCYNEXIS (NASDAQ:SCYX) on 12/18/2023
PFE Pfizer	$27.56	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 12/18/2023
PDSB PDS Biotechnology	$5.26 -0.6%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of PDS Biotechnology (NASDAQ:PDSB) on 12/18/2023
PCVX Vaxcyte	$74.14 +0.9%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Vaxcyte (NASDAQ:PCVX) on 12/18/2023
NVO Novo Nordisk A/S	$118.39 -0.2%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 12/18/2023

MRK Merck & Co., Inc.	$126.61 -0.7%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 12/18/2023
MESO Mesoblast	$1.82 +1.7%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Mesoblast (NASDAQ:MESO) on 12/18/2023
LYRA Lyra Therapeutics	$4.81 -1.8%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Lyra Therapeutics (NASDAQ:LYRA) on 12/18/2023
LLY Eli Lilly and Company	$735.56 +1.4%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 12/18/2023
JNJ Johnson & Johnson	$156.43 -1.0%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 12/18/2023
IMAB I-Mab	$1.79 -10.5%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of I-Mab (NASDAQ:IMAB) on 12/18/2023
HCM HUTCHMED	$13.93 +1.7%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of HUTCHMED (NASDAQ:HCM) on 12/18/2023
ATOS Atossa Therapeutics	$0.94 -1.1%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Atossa Therapeutics (NASDAQ:ATOS) on 12/18/2023
ARDX Ardelyx	$9.27 +3.3%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Ardelyx (NASDAQ:ARDX) on 12/18/2023
ANL Adlai Nortye	$8.86 -0.4%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Adlai Nortye (NASDAQ:ANL) on 12/18/2023
AMRN Amarin	$1.23 +2.5%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Amarin (NASDAQ:AMRN) on 12/18/2023
AMAM Ambrx Biopharma	$27.79	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight		Low	View details for Cantor Fitzgerald rating of Ambrx Biopharma (NYSE:AMAM) on 12/18/2023
ACRS Aclaris Therapeutics	$1.18 +11.3%	12/18/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Neutral		Low	View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 12/18/2023
QURE uniQure	$5.47 -2.5%	12/20/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$21.00	Low	View details for Cantor Fitzgerald rating of uniQure (NASDAQ:QURE) on 12/20/2023
ASND Ascendis Pharma A/S	$139.25 0.0%	12/20/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$152.00	Low	View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 12/20/2023
AXSM Axsome Therapeutics	$95.68 +1.8%	12/20/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$108.00	Low	View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 12/20/2023
BIIB Biogen	$240.30 -0.1%	12/20/2023	Reiterated by	Cantor Fitzgerald	Analyst E. Schmidt	Overweight -> Overweight	$311.00	Low	View details for Cantor Fitzgerald rating of Biogen (NASDAQ:BIIB) on 12/20/2023
IRON Disc Medicine	$66.73 +2.3%	12/20/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$85.00	Low	View details for Cantor Fitzgerald rating of Disc Medicine (NASDAQ:IRON) on 12/20/2023
CCJ Cameco	$44.72 -6.9%	12/19/2023	Downgraded by	Cantor Fitzgerald	-	Buy -> Neutral		Low	View details for Cantor Fitzgerald rating of Cameco (NYSE:CCJ) on 12/19/2023
LBPH Longboard Pharmaceuticals	$19.32 -6.1%	12/19/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$35.00	Low	View details for Cantor Fitzgerald rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 12/19/2023
CIFR Cipher Mining	$2.90 +15.5%	12/19/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$6.00	Low	View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 12/19/2023
CRNX Crinetics Pharmaceuticals	$38.46 +1.8%	12/19/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$50.00	Low	View details for Cantor Fitzgerald rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 12/19/2023
ADMA ADMA Biologics	$5.17 -0.2%	12/19/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$6.00	Low	View details for Cantor Fitzgerald rating of ADMA Biologics (NASDAQ:ADMA) on 12/19/2023
TSHA Taysha Gene Therapies	$1.56 +1.3%	12/18/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$7.00	Low	View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 12/18/2023
PTCT PTC Therapeutics	$25.25 +0.0%	12/18/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$51.00	Low	View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 12/18/2023
PRTA Prothena	$27.43 +3.1%	12/18/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$129.00	Low	View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 12/18/2023
CNC Centene	$76.50 +2.1%	12/15/2023	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$82.00 -> $90.00	Low	View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 12/15/2023
ITCI Intra-Cellular Therapies	$71.60 +4.4%	12/14/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$101.00	Low	View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 12/14/2023
ACAD ACADIA Pharmaceuticals	$25.68 +1.9%	12/14/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$42.00	Low	View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 12/14/2023
ALNY Alnylam Pharmaceuticals	$169.50 +0.5%	12/14/2023	Reiterated by	Cantor Fitzgerald	-	Neutral -> Neutral	$165.00	Low	View details for Cantor Fitzgerald rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 12/14/2023
VRTX Vertex Pharmaceuticals	$423.06 +0.9%	12/14/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$380.00	Low	View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 12/14/2023
LFMD LifeMD	$5.79 +1.4%	12/14/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$9.00	Low	View details for Cantor Fitzgerald rating of LifeMD (NASDAQ:LFMD) on 12/14/2023
ML MoneyLion	$48.90 +1.8%	12/13/2023	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$30.00 -> $58.00	Low	View details for Cantor Fitzgerald rating of MoneyLion (NYSE:ML) on 12/13/2023
KRYS Krystal Biotech	$111.03 -0.1%	12/13/2023	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$160.00 -> $180.00	Low	View details for Cantor Fitzgerald rating of Krystal Biotech (NASDAQ:KRYS) on 12/13/2023
MVST Microvast	$0.93 +3.3%	12/13/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$8.00	Low	View details for Cantor Fitzgerald rating of Microvast (NASDAQ:MVST) on 12/13/2023
FUBO fuboTV	$1.96 +1.0%	12/12/2023	Initiated by	Cantor Fitzgerald	-	Overweight	$5.00	Low	View details for Cantor Fitzgerald rating of fuboTV (NYSE:FUBO) on 12/12/2023
CXM Sprinklr	$12.85 +2.8%	12/7/2023	Target Lowered by	Cantor Fitzgerald	-	Overweight -> Overweight	$21.00 -> $16.00	Low	View details for Cantor Fitzgerald rating of Sprinklr (NYSE:CXM) on 12/7/2023
CERE Cerevel Therapeutics	$42.18 +1.6%	12/7/2023	Downgraded by	Cantor Fitzgerald	Analyst C. Duncan	Overweight -> Neutral	$38.00 -> $45.00	Low	View details for Cantor Fitzgerald rating of Cerevel Therapeutics (NASDAQ:CERE) on 12/7/2023
VRTX Vertex Pharmaceuticals	$423.06 +0.9%	12/5/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$380.00	Low	View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 12/5/2023
GTLB GitLab	$76.19 +4.7%	12/5/2023	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$55.00 -> $65.00	Low	View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 12/5/2023
LUNR Intuitive Machines	$3.78 +8.0%	12/5/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$4.00	Low	View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 12/5/2023
RIOT Riot Platforms	$13.05 +15.3%	12/4/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$19.00	N/A	View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 12/4/2023
IREN Iris Energy	$5.10 +23.8%	12/4/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$10.00	Low	View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 12/4/2023
CIFR Cipher Mining	$2.90 +15.5%	12/4/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$6.00	Low	View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 12/4/2023
CRNX Crinetics Pharmaceuticals	$38.46 +1.8%	12/4/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$50.00	Low	View details for Cantor Fitzgerald rating of Crinetics Pharmaceuticals (NASDAQ:CRNX) on 12/4/2023
RCM R1 RCM	$10.57 +1.9%	12/4/2023	Reiterated by	Cantor Fitzgerald	Analyst S. James	Overweight -> Overweight	$20.00	Low	View details for Cantor Fitzgerald rating of R1 RCM (NASDAQ:RCM) on 12/4/2023
BIVI BioVie	$1.10 +3.8%	11/30/2023	Downgraded by	Cantor Fitzgerald	Analyst C. Duncan	Overweight -> Neutral		Low	View details for Cantor Fitzgerald rating of BioVie (NASDAQ:BIVI) on 11/30/2023
CLSK CleanSpark	$10.50 +12.8%	12/1/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$10.00	Low	View details for Cantor Fitzgerald rating of CleanSpark (NASDAQ:CLSK) on 12/1/2023
NVO Novo Nordisk A/S	$118.39 -0.2%	12/1/2023	Initiated by	Cantor Fitzgerald	Analyst L. Chen	Overweight	$120.00	Low	View details for Cantor Fitzgerald rating of Novo Nordisk A/S (NYSE:NVO) on 12/1/2023
REE REE Automotive	$6.12 +1.5%	12/1/2023	Reiterated by	Cantor Fitzgerald	Analyst A. Sheppard	Neutral -> Underweight		Low	View details for Cantor Fitzgerald rating of REE Automotive (NASDAQ:REE) on 12/1/2023

MRK Merck & Co., Inc.	$126.61 -0.7%	11/29/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$135.00	Low	View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 11/29/2023
CRWD CrowdStrike	$323.04 +1.7%	11/29/2023	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$180.00 -> $240.00	Low	View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 11/29/2023
BITF Bitfarms	$2.52 +10.5%	11/29/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$2.00	Low	View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 11/29/2023
NNOX Nano-X Imaging	$5.74 +1.6%	11/29/2023	Target Lowered by	Cantor Fitzgerald	-	Overweight -> Overweight	$30.00 -> $24.00	Low	View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 11/29/2023
MVST Microvast	$0.93 +3.3%	11/29/2023	Initiated by	Cantor Fitzgerald	-	Overweight	$8.00	Low	View details for Cantor Fitzgerald rating of Microvast (NASDAQ:MVST) on 11/29/2023
ZS Zscaler	$249.41 +1.9%	11/28/2023	Target Raised by	Cantor Fitzgerald	-	Neutral -> Neutral	$170.00 -> $185.00	Low	View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 11/28/2023
RIOT Riot Platforms	$13.05 +15.3%	11/27/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$19.00	N/A	View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 11/27/2023
MIRM Mirum Pharmaceuticals	$27.02 +1.0%	11/27/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$50.00	Low	View details for Cantor Fitzgerald rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 11/27/2023
SLS SELLAS Life Sciences Group	$0.78 +6.9%	11/22/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$3.00	Low	View details for Cantor Fitzgerald rating of SELLAS Life Sciences Group (NASDAQ:SLS) on 11/22/2023
GTLB GitLab	$76.19 +4.7%	11/22/2023	Initiated by	Cantor Fitzgerald	-	Overweight	$55.00	Low	View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 11/22/2023
CNC Centene	$76.50 +2.1%	11/21/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$82.00	Low	View details for Cantor Fitzgerald rating of Centene (NYSE:CNC) on 11/21/2023
CVS CVS Health	$75.09 -1.3%	11/21/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$87.00	Low	View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 11/21/2023
ELV Elevance Health	$502.05 +0.9%	11/21/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$547.00	Low	View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 11/21/2023
HUM Humana	$367.65 -0.2%	11/21/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$597.00	Low	View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 11/21/2023
MOH Molina Healthcare	$381.32 +5.3%	11/21/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$374.00	Low	View details for Cantor Fitzgerald rating of Molina Healthcare (NYSE:MOH) on 11/21/2023
UNH UnitedHealth Group	$520.01 +0.1%	11/21/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$591.00	Low	View details for Cantor Fitzgerald rating of UnitedHealth Group (NYSE:UNH) on 11/21/2023
CRWD CrowdStrike	$323.04 +1.7%	11/21/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$180.00	Low	View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 11/21/2023
FTNT Fortinet	$67.85 -3.1%	11/21/2023	Reiterated by	Cantor Fitzgerald	Analyst J. Ruykhaver	Neutral -> Neutral	$50.00	Low	View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 11/21/2023
ZS Zscaler	$249.41 +1.9%	11/21/2023	Reiterated by	Cantor Fitzgerald	-	Neutral -> Neutral	$170.00	Low	View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 11/21/2023
SYM Symbotic	$42.99 +9.4%	11/21/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$60.00	Low	View details for Cantor Fitzgerald rating of Symbotic (NASDAQ:SYM) on 11/21/2023
RCEL AVITA Medical	$17.60 +3.3%	11/21/2023	Reiterated by	Cantor Fitzgerald	Analyst R. Osborn	Overweight -> Overweight	$20.00	Low	View details for Cantor Fitzgerald rating of AVITA Medical (NASDAQ:RCEL) on 11/21/2023
PFE Pfizer	$27.56	11/20/2023	Reiterated by	Cantor Fitzgerald	Analyst L. Chen	Overweight -> Overweight	$75.00	Low	View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 11/20/2023
BITF Bitfarms	$2.52 +10.5%	11/20/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$2.00	Low	View details for Cantor Fitzgerald rating of Bitfarms (NASDAQ:BITF) on 11/20/2023
CIFR Cipher Mining	$2.90 +15.5%	11/20/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$6.00	Low	View details for Cantor Fitzgerald rating of Cipher Mining (NASDAQ:CIFR) on 11/20/2023
CLSK CleanSpark	$10.50 +12.8%	11/20/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$10.00	Low	View details for Cantor Fitzgerald rating of CleanSpark (NASDAQ:CLSK) on 11/20/2023
PTCT PTC Therapeutics	$25.25 +0.0%	11/20/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$51.00	Low	View details for Cantor Fitzgerald rating of PTC Therapeutics (NASDAQ:PTCT) on 11/20/2023
GRCL Gracell Biotechnologies	$10.23	11/15/2023	Reiterated by	Cantor Fitzgerald	Analyst J. Schimmer	Overweight		Low	View details for Cantor Fitzgerald rating of Gracell Biotechnologies (NASDAQ:GRCL) on 11/15/2023
JNJ Johnson & Johnson	$156.43 -1.0%	11/17/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$215.00	Low	View details for Cantor Fitzgerald rating of Johnson & Johnson (NYSE:JNJ) on 11/17/2023
PAGS PagSeguro Digital	$13.23 +0.2%	11/17/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$14.00	Low	View details for Cantor Fitzgerald rating of PagSeguro Digital (NYSE:PAGS) on 11/17/2023
GDYN Grid Dynamics	$13.96 +0.1%	11/17/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$14.00	Low	View details for Cantor Fitzgerald rating of Grid Dynamics (NASDAQ:GDYN) on 11/17/2023
PANW Palo Alto Networks	$367.02 +0.7%	11/16/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$280.00	Low	View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 11/16/2023
VRTX Vertex Pharmaceuticals	$423.06 +0.9%	11/16/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$380.00	Low	View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 11/16/2023
VNRX VolitionRx	$1.18 -0.8%	11/16/2023	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$2.10 -> $2.50	Low	View details for Cantor Fitzgerald rating of VolitionRx (NYSE:VNRX) on 11/16/2023
STNE StoneCo	$18.16 +1.1%	11/16/2023	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$18.00 -> $21.00	Low	View details for Cantor Fitzgerald rating of StoneCo (NASDAQ:STNE) on 11/16/2023
ASXC Asensus Surgical	$0.29 +7.5%	11/16/2023	Downgraded by	Cantor Fitzgerald	Analyst R. Osborn	Overweight -> Neutral		N/A	View details for Cantor Fitzgerald rating of Asensus Surgical (NYSEAMERICAN:ASXC) on 11/16/2023
MIRM Mirum Pharmaceuticals	$27.02 +1.0%	11/15/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$50.00	Low	View details for Cantor Fitzgerald rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 11/15/2023
LLY Eli Lilly and Company	$735.56 +1.4%	11/15/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$630.00	Low	View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 11/15/2023
MRK Merck & Co., Inc.	$126.61 -0.7%	11/15/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$135.00	Low	View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 11/15/2023
SMTI Sanara MedTech	$40.20 +4.1%	11/15/2023	Target Lowered by	Cantor Fitzgerald	-	Overweight -> Overweight	$59.00 -> $49.00	Low	View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 11/15/2023
TSHA Taysha Gene Therapies	$1.56 +1.3%	11/15/2023	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$6.00 -> $7.00	Low	View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 11/15/2023
CABA Cabaletta Bio	$25.38 +7.6%	11/15/2023	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$40.00 -> $50.00	Low	View details for Cantor Fitzgerald rating of Cabaletta Bio (NASDAQ:CABA) on 11/15/2023
BMY Bristol-Myers Squibb	$48.71 +0.1%	11/15/2023	Downgraded by	Cantor Fitzgerald	Analyst O. Brayer	Overweight -> Neutral	$68.00 -> $55.00	Low	View details for Cantor Fitzgerald rating of Bristol-Myers Squibb (NYSE:BMY) on 11/15/2023
ELUT Elutia	$3.71 -1.1%	11/14/2023	Target Lowered by	Cantor Fitzgerald	-	Overweight -> Overweight	$8.00 -> $6.00	Low	View details for Cantor Fitzgerald rating of Elutia (NASDAQ:ELUT) on 11/14/2023
MVIS MicroVision	$2.47 +4.2%	11/14/2023	Target Lowered by	Cantor Fitzgerald	-	Neutral -> Neutral	$4.00 -> $3.00	Low	View details for Cantor Fitzgerald rating of MicroVision (NASDAQ:MVIS) on 11/14/2023
JOBY Joby Aviation	$5.77 +2.1%	11/14/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$10.00	Low	View details for Cantor Fitzgerald rating of Joby Aviation (NYSE:JOBY) on 11/14/2023
WULF TeraWulf	$2.03 +18.0%	11/14/2023	Target Lowered by	Cantor Fitzgerald	-	Overweight -> Overweight	$4.00 -> $3.00	Low	View details for Cantor Fitzgerald rating of TeraWulf (NASDAQ:WULF) on 11/14/2023
LFMD LifeMD	$5.79 +1.4%	11/14/2023	Target Raised by	Cantor Fitzgerald	-	Overweight -> Overweight	$8.00 -> $9.00	Low	View details for Cantor Fitzgerald rating of LifeMD (NASDAQ:LFMD) on 11/14/2023
ACRS Aclaris Therapeutics	$1.18 +11.3%	11/14/2023	Downgraded by	Cantor Fitzgerald	Analyst L. Chen	Overweight -> Neutral		Low	View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 11/14/2023
TMC TMC the metals	$1.28	11/13/2023	Initiated by	Cantor Fitzgerald	-	Buy	$4.20	Low	View details for Cantor Fitzgerald rating of TMC the metals (NASDAQ:TMC) on 11/13/2023
SOUN SoundHound AI	$1.95 +14.0%	11/10/2023	Target Lowered by	Cantor Fitzgerald	-	Overweight -> Overweight	$4.20 -> $3.60	Low	View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 11/10/2023
EVLV Evolv Technologies	$5.07 +10.5%	11/10/2023	Target Lowered by	Cantor Fitzgerald	-	Overweight -> Overweight	$9.00 -> $8.00	Low	View details for Cantor Fitzgerald rating of Evolv Technologies (NASDAQ:EVLV) on 11/10/2023
OMER Omeros	$3.31 +0.6%	11/10/2023	Downgraded by	Cantor Fitzgerald	Analyst O. Brayer	Overweight -> Neutral		Low	View details for Cantor Fitzgerald rating of Omeros (NASDAQ:OMER) on 11/10/2023
NPCE NeuroPace	$16.91 +1.8%	11/10/2023	Initiated by	Cantor Fitzgerald	Analyst R. Osborn	Overweight	$11.00	Low	View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 11/10/2023
TWOU 2U	$0.76 +7.1%	11/10/2023	Downgraded by	Cantor Fitzgerald	-	Overweight -> Neutral	$5.30 -> $1.50	Low	View details for Cantor Fitzgerald rating of 2U (NASDAQ:TWOU) on 11/10/2023
MLTX MoonLake Immunotherapeutics	$61.25 +2.2%	11/8/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$78.00	Low	View details for Cantor Fitzgerald rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/8/2023
BCYC Bicycle Therapeutics	$16.80 +0.3%	11/8/2023	Reiterated by	Cantor Fitzgerald	-	Overweight -> Overweight	$65.00	Low	View details for Cantor Fitzgerald rating of Bicycle Therapeutics (NASDAQ:BCYC) on 11/8/2023
RIVN Rivian Automotive	$16.11 +6.2%	11/8/2023	Target Lowered by	Cantor Fitzgerald	-	Overweight -> Overweight	$29.00 -> $27.00	Low	View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 11/8/2023
CERS Cerus	$2.30 +4.5%	11/8/2023	Reiterated by	Cantor Fitzgerald	Analyst R. Osborn	Overweight	$9.00 -> $3.00	Low	View details for Cantor Fitzgerald rating of Cerus (NASDAQ:CERS) on 11/8/2023
SHLS Shoals Technologies Group	$15.44 +0.6%	11/8/2023	Reiterated by	Cantor Fitzgerald	Analyst D. Soderberg	Overweight -> Overweight	$28.00	Low	View details for Cantor Fitzgerald rating of Shoals Technologies Group (NASDAQ:SHLS) on 11/8/2023
PRCH Porch Group	$2.40 +7.6%	11/8/2023	Target Lowered by	Cantor Fitzgerald	Analyst J. Siegler	Overweight -> Overweight	$6.00 -> $3.00	Low	View details for Cantor Fitzgerald rating of Porch Group (NASDAQ:PRCH) on 11/8/2023

MarketBeat Community Rating for Cantor Fitzgerald

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		22,972 (Vote Outperform)
Underperform Votes:		19,666 (Vote Underperform)
Total Votes:		42,638

MarketBeat's community ratings are surveys of what our community members think about Cantor Fitzgerald and other research firms. Vote "Outperform" if you believe Cantor Fitzgerald's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Cantor Fitzgerald's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cantor Fitzgerald Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Cantor Fitzgerald

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info